That's a big assumption. They haven't done so over the past few years. Hopefully this will be an opportunity to give the board and executive a clean out and put some decent talent in there.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025